American drug retail company
POPULARITY
Send us a textWhat if better care starts with more trust and understanding?In this episode of CareTalk, Violet CEO Gaurang Choksi joins John Driscoll to explore why care can't be one-size-fits-all and what happens when providers actually understand the identities and experiences of the people they treat. Drawing from his journey as a gay immigrant and early leader at Oscar Health, Gaurang shares how culturally competent care leads to stronger relationships and better outcomes for the patients who've long felt unseen.
Send us a textThe FDA is charging ahead with generative AI, claiming it can cut scientific review times from days to minutes. But is this innovation or recklessness? In this episode of CareTalk, David Williams and John Driscoll debate whether the FDA's rapid deployment of AI is a smart move or a potentially dangerous shortcut.Stream our episode with FDA leader, Dr. Marty Makary, here.
Send us a textHealth coaching is often overlooked in healthcare, but could it be the key to improving behavior change, supporting chronic care, and filling gaps left by clinical shortages? In this episode of CareTalk: Healthcare. Unfiltered., Eugene Borukhovich, COO & Co-Founder of YourCoach, joins John Driscoll to discuss why coaching is gaining traction, how YourCoach is helping scale it, and why embracing health coaches could be critical to building a stronger, more sustainable healthcare system.
Send us a textMedicaid spending is almost certain to get cut significantly under the emerging Congressional reconciliation bill. But what is Medicaid anyway and what will happen if spending drops?
Send us a textChronic pain affects more Americans than cancer, heart disease, and diabetes combined, yet it remains one of the most misunderstood and poorly managed health conditions.In this episode of the CareTalk Podcast, John Driscoll sits down with Jennie Shulkin, Founder of Override Health, to discuss how her personal experience with chronic pain led to building a virtual, team-based care model that can revolutionize pain management as we know it.
China MOFCOM says China strongly opposes 50% additional tariffs and urges resolution of disputes with United States via dialogue.European bourses are on a firmer footing with US futures also in the green; ES +1.5%.USD softer vs. most major peers, antipodeans lead, EUR/USD remains on a 1.09 handle.Bonds were initially contained but has recently given way to pressure as the risk tone recovers.Crude choppy in a tight range while metals benefit from a softer Dollar ahead of trade updates.Looking ahead, ECB's Cipollone, BoE's Lombardelli & Fed's Daly, Supply from the US, Earnings incl. Walgreens Boots Alliance.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk
Send us a textMeasles is making a comeback, and with it comes a heated debate on vaccine mandates, public health, and personal freedom. In this episode of CareTalk, Michael F. Cannon (Director of Health Policy Studies, Cato Institute) joins hosts, David E. Williams and John Driscoll, to debate the challenges of balancing individual rights with public safety, why vaccine mandates can backfire, and how misinformation fuels the controversy.
Years ago, an ailing company like Walgreens Boots Alliance may have seemed like a prime acquisition target for deal-hungry private equity firms. But many have backed away from retail recently, leaving an opening for groups like Sycamore Partners who are willing to buck the trend. Sycamore announced this month that it would take the global pharmacy business private in a $23.7bn debt and equity deal. The FT's Due Diligence reporter, Amelia Pollard, explains the well-worn playbook that Sycamore has used on past retail companies, and whether it will work this time with a chain that has its own share of unique problems. Clips from Bloomberg, CNBC, CBS- - - - - - - - - - - - - - - - - - - - - - - - - - For further reading:Retail's last barbarian: the private equity group about to play hardball with BootsWhat went wrong after Walgreens bought Boots? Walgreens bondholders could be winners from its debt-laden buyout- - - - - - - - - - - - - - - - - - - - - - - - - - Follow Amelia Pollard (@ameliajpollard) on X or (@pollard.bsky.social) on Bluesky. Michela Tindera is on X (@mtindera07) and Bluesky (@mtindera.ft.com), or follow her on LinkedIn for updates about the show and more. For more from Amelia and her team, sign up for the Due Diligence newsletter. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
In this episode of The Deal Room, Anthony and Stephen break down the latest high-stakes deals shaking up the investment banking world. From Goldman Sachs' $19 billion port sale and cost-cutting strategy (Project Voyage) to UBS's role in the Walgreens Boots Alliance buyout, they uncover the strategies driving these financial powerhouses.Plus, they explore Europe's push for aerospace self-sufficiency and what Barclays' leadership shake-up means for its ambitious expansion in equity capital markets.If you want to stay ahead of the curve in all things investment banking and private equity, this episode is for you!(00:00) Introduction to The Deal Room & Topics(03:30) Goldman Sachs: Major Deals and Strategies(13:18) Project Voyage: Cost-Cutting and Relocation(18:57) European Aerospace and Defense: Shifts in Advisory(24:37) UBS and the Walgreens Boots Alliance Buyout(31:23) Barclays: Leadership Changes in ECM Hosted on Acast. See acast.com/privacy for more information.
Send us a textIn this episode of CareTalk, John Driscoll sits down with Oron Afek, CEO of Vim, to discuss how Vim is transforming healthcare by creating a smarter, more connected ecosystem for doctors and patients. Oron shares his entrepreneurial journey, from his early days in the Israeli military to building a healthcare platform that integrates seamlessly with electronic health records (EHRs) to improve clinical decision-making. Learn how Vim's technology is helping doctors make better decisions at the point of care, streamlining workflows, and driving better patient outcomes, all while empowering developers to build innovative healthcare solutions.
US equity futures are pointing to a higher open today. European markets have opened in the negative territory, following weaker Asian sessions. Global markets still have their attention on Trump, who has agreed to delay the 25% tariffs on Canadian and Mexican goods covered by the USMCA until April second. Still, the tariff reprieve provided no support for markets given the uncertain policy dynamic and Trump showing little inclination to back down from his broader strategy of remaking trade relationships. Companies mentioned: Walgreens Boots Alliance, Apollo Global
United Natural Foods Inc. workers in Atlanta hold a practice picket as they await their first contract. Alimentation Couche-Tard Inc. explores divesting U.S. c-stores to secure regulatory approval for the potential acquisition of Seven & i Holdings. And Sycamore Partners is acquiring Walgreens Boots Alliance for $10 billion.
Walgreens Boots Alliance has entered a $10 billion agreement to go private with Sycamore Partners, ending nearly 100 years as a public company. Sycamore will pay $11.45 per share in cash, with potential additional payouts for Walgreens' primary-care assets, bringing the deal's total value to $23.7 billion including debt. The transaction will close in the fourth quarter of 2025, resulting in Walgreens' common stock being removed from the Nasdaq Stock Market. The company's market value has decreased significantly from $100 billion in 2015 to approximately $9.8 billion today, with a reported net loss of $8.6 billion in fiscal year 2024, leading to the closure of around 1,000 stores since 2018 and plans for 1,200 more. The Sycamore acquisition allows Walgreens to prioritize business recovery without public pressure. Walgreens also faces legal challenges, including a lawsuit from Cooler Screens regarding the rollout of digital cooler doors.Learn more on this news visit us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.
Repasamos la FED, Broadcom, Hewlett Packard, Walgreens Boots Alliance y echamos un vistazo a las declaraciones de Trump, donde ha culpado a "los globalistas" de las caídas que registra Wall Street. Con Javier Aledo, analista de AFI.
Send us a textWhole-person care is the gold standard for treating elderly patients by delivering care where they need it when they need it, but traditional healthcare models make it tough to scale.Can value-based care and home-based medicine change that?In this episode of CareTalk, host John Driscoll speaks with Jeffrey Kang, CEO of WellBe, to explore the challenges and opportunities of geriatric care, the evolution of Medicare risk adjustment, and why integrating whole-person care into value-based models is key to keeping vulnerable patients healthier.
Send us a textA New York doctor has been indicted for prescribing abortion pills to a patient in Louisiana, sparking a legal showdown between the two states.Now, New York is striking back with a law to shield physicians. Which state will prevail?In this episode of CareTalk, hosts David E Williams and John Driscoll unpack the fight over abortion pill prescriptions and what it means for the future of reproductive rights across the country.TOPICS(0:20) Introduction(0:35) Why Did Louisiana Indict a Doctor from New York?(2:04) The Impact of Political Strategy on Healthcare(3:29) The State's Role in Abortion Policy(6:48) How New York and Abortion Advocates Are Striking Back(7:28) Understanding Laws Protecting Providers(10:09) How Trump Will Influence Abortion Policy(11:23) How Pharmacies Are Reacting to Conflicting Policies(13:22) Hope for the Future of Healthcare in America
In episode 232 of the Dividend Talk podcast, we discuss recent earnings reports, political developments in the US and Europe, and listener questions. We discuss UPS's decision to drop Amazon as a major customer, Donald Trump's first week in office and his tariff threats, and the EU's plan to boost competitiveness. We also cover recent dividend announcements from companies like Walgreens Boots Alliance, LVMH, Shell, and Evolution AB. Finally, we answer listener questions on topics such as AI tools for analyzing company finances, the impact of politics on investment decisions, and the attractiveness of Canadian insurance companies. Tickers mentioned - UPS, Amazon, DHL, FedEx, Phillips, Walgreens Boot Alliance, LVMH, Shell, Evolution AB, Axonobel, KPN, Novartis, Starbucks, Abbvie see you on the inside! Check out our Newsletter here - Download Your Free Samples – Dividend Talk
Send us a textOpioid makers and distributors are paying over $50 billion to settle lawsuits with states and cities.But how is this settlement money being spent?And is the opioid crisis nearing an end?In this episode of CareTalk, David E. Williams and John Driscoll explore the impacts of recent opioid lawsuits and whether they could finally put an end to the crisis.TOPICS(0:30) Examining the Opioid Settlement(2:50) The Difference Between the Opioid and Tobacco Settlements(4:47) What Are the Settlement Funds Being Used For?(7:09) What's the Impact of the Opioid Settlement?(8:40) What Should States Do With Their Settlement Money?(9:06) The Waves of the Opioid Epidemic(12:50) Combating Waves of Fentanyl and Stimulants(13:53) The Pitfalls in Opioid Addiction Treatment(16:08) Preventing Opioid Addiction(18:27) The Role of Mental Health in Opioid Addiction(20:44) Avoiding Fentanyl With Test Strips
APAC stocks were mostly subdued in the absence of a lead from Wall St owing to the National Day of Mourning.US President-elect Trump said Russian President Putin wants to meet and 'we' are setting it up.Fed's Bowman (voter) said she supported the December rate cut as a final step in policy calibration.European equity futures indicate an uneventful cash market open with Euro Stoxx 50 future -0.1% after the cash market closed with gains of 0.4% on Thursday.USD is broadly firmer vs. peers, EUR/USD continued to pivot around 1.03, Cable remains sub-1.23.Looking ahead, highlights include US & Canadian Jobs, US UoM Survey, Chinese M2 Money Supply, FDI, Loan Growth, earnings from Sainsbury's, Tilray, Delta Air, Walgreens Boots Alliance & Constellation Brands.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk
European bourses trade choppy, US futures edge lower ahead of the US NFP report.USD eyes NFP, JPY boosted by BoJ source report, GBP unable to recoup lost ground.Fixed income a touch lower ahead of US jobs data, Gilts continue to underperform.Crude soars on geopolitical updates, Industrial commodities bolstered by Chinese commentary.Looking ahead, US & Canadian Jobs, US UoM Survey, Chinese M2 Money Supply, FDI, Loan Growth, Earnings from Tilray, Delta Air, Walgreens Boots Alliance & Constellation Brands.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk
In this episode, Scott Becker examines the recent struggles of four major stocks—SoundHound, Moderna, Walgreens Boots Alliance, and Palantir Technologies.
In this episode, Scott Becker examines the recent struggles of four major stocks—SoundHound, Moderna, Walgreens Boots Alliance, and Palantir Technologies.
January 6, 2025 | Season 7, Episode 1What if you could navigate the unpredictable waters of the 2025 investment landscape like a seasoned pro? Get ready to unlock the secrets of booming market trends and lucrative investment opportunities that await in the new year. Our latest episode takes you on a journey through the economic milestones of 2024, highlighting an impressive 24% surge in the S&P 500 and the contrasting fortunes of growth versus value stocks. We'll unravel the stories behind the triumph of tech titans like Palantir Technologies and Nvidia, while examining the struggles faced by Walgreens Boots Alliance and Intel. With exciting developments on the horizon, including Microsoft's ambitious $80 billion AI data center plan, we'll set the stage for potential market shifts based on Nvidia's CEO's much-anticipated address.Join us as we explore promising avenues in healthcare and consumer stocks, spotlighting giants like Eli Lilly, UnitedHealthcare, and Johnson & Johnson, amidst potential policy changes with RFK Jr.'s influence. We'll dissect the tech sector's fierce competition between XAI and OpenAI, alongside Google's strategic advancements. Discover Apple's robust market position and its intricate ties with China, all while weighing the impacts of federal cases. We'll also guide you through the enticing realms of REITs, energy pipelines, and utilities, offering cautionary insights on junk bonds and convertibles. Finally, grasp the potential of European stocks, with BNP Paribas poised as a compelling opportunity in the international arena, especially as Federal Reserve rate cuts loom over dividends.** For informational and educational purposes only, not intended as investment advice. Views and opinions are subject to change without notice. For full disclosures, ADVs, and CRS Forms, please visit https://heroldlantern.com/disclosure **To learn about becoming a Herold & Lantern Investments valued client, please visit https://heroldlantern.com/wealth-advisory-contact-formFollow and Like Us on Youtube, Facebook, Twitter, and LinkedIn | @HeroldLantern
How do you lead your company through tough times? Discover how to navigate turnarounds, build high-performing teams, and fosters a culture of respect and success with our guest, Tim Wentworth, CEO of Walgreens Boots Alliance. Tim shares his incredible journey from community college to the helm of Fortune 25 companies. From his early days in the music industry to leading major healthcare companies, Tim offers a unique perspective on building successful businesses and navigating challenges. We discuss the importance of company culture, the power of teamwork, and the critical role of customer focus in achieving success. Gain valuable leadership lessons from a seasoned executive and discover how to apply them to your own career, whether you're just starting out or leading a large organization. Connect with Tim - LinkedIn. Learn more about Walgreens Boots Alliance on Instagram - LinkedIn or visit walgreensbootsalliance.com. Follow Real Estate Insiders Unfiltered Podcast on Instagram - YouTube - Facebook - TikTok. Visit us online at realestateinsidersunfiltered.com. Link to Facebook Page: https://www.facebook.com/RealEstateInsidersUnfiltered Link to Instagram Page: https://www.instagram.com/realestateinsiderspod/ Link to YouTube Page: https://www.youtube.com/@RealEstateInsidersUnfiltered Link to TikTok Page: https://www.tiktok.com/@realestateinsiderspod This podcast is produced by Two Brothers Creative.
Send us a textHealth systems are constantly struggling with capacity constraints.But what if they already had all the capacity they needed and just needed to tap into it? In this episode of HealthBiz Briefs, Derek Streat, Co-Founder and CEO of DexCare, shares how health leaders can unlock hidden capacity by using data from patients, providers, and health systems to deliver care more efficiently.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
In this episode, Scott Becker examines five major stocks with significant losses this year, including Walgreens Boots Alliance, Intel, Moderna, SiriusXM, and Avis Budget, with declines ranging from 54% to 65%.
Send us a text2024 shook up the healthcare world, and 2025 is gearing up to be just as transformative.With big changes coming from the new Administration, the AI boom taking healthcare by storm, and the rapid rise of GLP-1s, next year is shaping up to be a wild ride.Join David E. Williams and John Driscoll on CareTalk as they dust off their crystal ball and explore what's in store for healthcare in 2025!This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS(0:30) Sponsorship(1:50) Thank You to Our Audience(2:47) Predictions for GLP-1s(8:28) The Rise of AI in Healthcare(12:12) How the New Administration Will Affect Public Health(15:05) Healthcare on the Defense(18:54) Boosting Primary and Value-Based Care(22:06) The Growth of the Healthcare Market
In this episode, Scott Becker examines five major stocks with significant losses this year, including Walgreens Boots Alliance, Intel, Moderna, SiriusXM, and Avis Budget, with declines ranging from 54% to 65%.
Send us a textSpeech is something many of us take for granted, but for millions in the disability community, it can be a daily source of struggle and frustration.Augmentative and alternative communication (AAC) tools, such as sign language, are essential for those with speech disabilities to communicate. What if technology could help give a voice to those in need?In this episode of HealthBiz Briefs, Dougal Hawes, CEO of Smartbox Assistive Technology, explores how their AAC technology is empowering individuals with speech difficulties to communicate and live more independently.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
“I transitioned into FP&A when I realized that it wasn't just about crunching the numbers, it was more about telling a story and trying to influence the future. Working with Fortune 100 companies has given me the fantastic platform to leave transformative projects in finance, procurement, and supply chain. I saw firsthand how FP&A acts as the strategic backbone of any type of organization” – Enrique Rodriguez, Finance Director, Walgreens Boots Alliance Enrique Rodriguez is a multilingual finance director and business leader. With more than 15 years of experience in Fortune 100 companies, he has worked collaboratively with global functions directing FP&A, accounting and treasury teams. He's headed finance departments overseeing $7 billion in annual spend and managing operational budgets of up to $750 million in billion dollar business units and is a passionate believer in Zero Based Budgeting revealing how he implemented this – despite challenges. My background in Guatemala When I realized it is not just about crunching the numbers FP&A as the backbone of the institution Main financial metrics bio biopharmaceutical companies, medical devices, and healthcare companies How FP&A departments are set up at the companies you worked for – and the philosophy and the outputs expected from FP&A producing outputs like dynamic scenario planning and specific KPI dashboards guiding decisions at the highest level. Zero based budgeting – the why and how of our experience Biggest challenges I have seen in budgeting in my career – managing budgets during a turnaround How finance business partnering has changed in my career The problem solving aspect of FP&A The opportunities and challenges of fast-growing technology Saving $8million on inventory write-off in a country on a health product Financial Executives International (Chicago) The power of a great mentor and books: Hit Refresh Satya Nadella (Microsoft) and Shoe Dog (Joe Knight) supporting a procurement organization in, in an early level of maturity – my toughest challenge Index Match – more flexible and scalable for complex analysis Connect with Enrique Rodriguez on LinkedIn: https://www.linkedin.com/in/enrique-a-rodriguez/
Send us a textAdministrative hassles and mountains of paperwork remain some of the biggest challenges in healthcare today.Every day, critical time and resources are diverted from doctors, nurses, and other medical staff to navigate inefficient prior authorizations and overwhelming paperwork. Isn't it time we find a better solution?In this episode of CareTalk, David E. Williams and John Driscoll sit down with Anterior Founder and CEO Abdel Mahmoud to explore the burden of administrative tasks on healthcare and how AI can bring clarity and efficiency to the chaos.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS(0:28) Sponsorship(1:40) Dr. Abdel Mahmoud's Military Experience(3:05) The Personal Journey of Dr. Abdel Mahmoud(5:35) Understanding Large Language Models(7:59) The Journey of Anterior(10:49) AI's Role in Managed Care(14:22) How Anterior is Different(15:52) How Anterior Uses Language Learning Models(20:27) The Future of Anterior(22:42) Using AI as Support(24:01) How Anterior Differentiates from the Competition(26:15) The Future of AI in Healthcare
Send us a textHernia surgery is one of the most common procedures, but the quality of care and post-op treatment can vary widely.What's behind these variations, and how can we ensure better care for patients?In this episode of HealthBiz Briefs, Dr. Michael Reinhorn and Dr. Nora Fullington dive into the challenges of hernia surgery and explain how Boston Hernia is raising the bar with patient-centered care and improved outcomes.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
Send us a textPrimary care is the foundation of a strong healthcare system, but it faces mounting challenges, from workforce shortages to reimbursement struggles. Is advanced primary care the solution and what would that model look like?In this episode of CareTalk, David E. Williams and John Driscoll sit down with Dr. Kate Goodrich, Chief Medical Officer of Humana, to explore the critical role of primary care and how it must evolve to meet the growing demands of patients, providers, and the healthcare system as a whole.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS(0:21) Intro(0:34) Sponsorship(2:05) The Advantages of Primary Care(3:51) Understanding Primary Care(5:06) Why Is Primary Care Struggling(6:55) The Current State of Primary Care(7:57) How Primary Care Is Changing(10:18) The Promise of Care Coordination in Primary Care(12:51) What Does Advanced Primary Care Look Like(15:20) Measuring Success in Primary Care(18:32) What Is Direct Primary Care(19:51) The State of Medicare Managed Care(23:43) Why Are Primary Care Physicians Unhappy
Send us a textWe're living in an era where health data is more accessible than ever.From lab results to wearable devices like the Apple Watch, there is an overwhelming amount of health information available. However, the real challenge lies in unlocking the potential of this data to drive transformative health improvements for both patients and providers.In this episode of HealthBiz Briefs, guest Richard Kedziora, Co-Founder and COO of Estenda, discusses how they are leveraging health data to uncover patterns and trends that lead to better treatments and improved patient outcomes.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
Carlos Romero believes that mentors hold the key for STEM education. His own story involved growing into success based on a foundation of the importance of education by his parents and the legacy of high achievement by his siblings. Carlos was inspired by teachers to take challenging steps that led him to a distinguished career in industry. Carlos Romero is the Manager of Global Technology at Walgreens Boots Alliance. Carlos serves as a board member of the National Math and Science Initiative (NMSI nms.org), a non-profit organization dedicated to equipping underserved schools and communities with vital STEM resources, and as an industry mentor at the University of Chicago's Pritzker School of Molecular Engineering.Carlos knows firsthand the impact that STEM leaders can make on young students as mentors and role models. He sees industry skills like problem solving, project management, and communication as vital skills for educators to be adding to their STEM learning.Connect with Omar:The National Math & Science Initiative nms.orgFree STEM Lessons from NMSILinkedIn: linkedin.com/in/cromerob/Chris Woods is the host of the STEM Everyday Podcast... Connect with him:Website: dailystem.comTwitter/X: @dailystemInstagram: @dailystemYouTube: @dailystemGet Chris's book Daily STEM on AmazonSupport the show
Send us a textGLP-1 medications like Novo Nordisk's Wegovy and Ozempic are taking the market by storm.With demand soaring, many patients are realizing these medications are either not being covered or simply too expensive.Is this all due to provider greed or is the issue more complicated?In this episode of CareTalk, David E. Williams and John Driscoll discuss how the growing demand for weight-loss drugs is creating a conundrum for providers, forcing them to decide between avoiding the costs associated with at-risk patients or investing upfront for long-term savings.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS(0:38) Sponsorship(2:06) Obesity in America(2:40) The State of Insurance Coverage for GLP-1s(3:27) Background on Obesity Drugs(4:45) Formation of GLP-1 Use(7:20) The Cost Conundrum of Weight-Loss Drugs(10:16) How Insurance Impacts Weight-Loss Drug Coverage(11:30) Understanding Adverse Selection(14:30) How Insurers Prevent Coverage(15:04) Decisions on Weight-Loss Drug Coverage(16:07) What Makes GLP-1s Unique for Cost Coverage(18:00) Will Weight-Loss Drugs Become Cheaper?(21:22) Medicare's Role in Weight-Loss Drugs(22:17) Examining Side Effects of Weight-Loss Drugs
Send us a textEver tried to schedule a doctor's appointment, only to be stuck on hold for what feels like forever?You're not alone. A lot of Americans feel the same frustration.Could there be a better way to take control of scheduling?In this episode of HealthBiz Briefs, Relatient CEO Jeff Gartland explains why self-scheduling is still a novel concept in medicine and how its implementation can improve patient access while increasing appointment volumes for providers.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
Send us a textWhat if you could get personalized medical solutions tailored exactly to your needs, diagnosis, and even genetics?Personalized medicine may have sounded like a pipe dream a few years ago, but it's fast becoming a major sector of the industry.In this episode of CareTalk, David Williams and John Driscoll sit down with Bradley Bostic, Founder and CEO of hc1 and managing director at Health Cloud Capital, to explore how diagnostics and AI are transforming personalized healthcare through data-driven innovation.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS(0:16) Intro(0:32) Sponsorship(2:11) Congratulations to Marty Makary(2:51) How Important Is Lab Testing for Healthcare?(4:38) Going Beyond Basic Lab Data(7:49) How Tests Lead Into Personalized Medicine(10:41) Looking at Data More Effectively(15:00) Will Changes in the Healthcare System Affect Lab Data?
Send us a textMany patients want to have a say in their medical care, especially when it comes to end-of-life decisions.Despite this, only a third of U.S. adults have completed any form of advance care directive.Even for those who do plan ahead, traditional paper-based advance directives often face challenges like misinterpretation or even being ignored altogether.Could video-recorded directives be the answer?In this episode of HealthBiz Briefs, MIDEO CEO Dr. Ferdinando Mirarchi sheds light on the limitations of standard advance care directives and explains why video-based solutions might deliver better results, offering greater clarity and ensuring patients' wishes are honored.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
Send us a textWord-of-mouth recommendations are great for picking a restaurant or movie, but are they the best way to find a doctor?What if there was a better way to use data to find the right doctor every time?In this episode of CareTalk, David Williams talks with Nick Reber, Founder and CEO of Garner Health, about how they're leveraging detailed data, including physician history and patient outcomes, to match patients with high-quality doctors.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS:(0:15) Sponsorship(1:45) Why Nick Reber Started Garner Health(4:50) Using Data to Find the Best Doctors(7:13) How Hedge Funds Relate to Healthcare(9:25) Measuring Patient Outcomes and Costs(11:20) Building Patient Trust(14:32) Dealing with Fragmented Data(16:29) Deciphering Complex Data to Determine Outcomes(20:24) Garner Health's Relation to Value-Based Care(23:18) Advice for Someone Starting a Healthcare Company
Send us a textCancer moves fast. Patients and their medical teams need to move faster.When crucial data about diagnosis, staging, and treatments gets held up, it can cost patients valuable time, resources, and treatment opportunities.In the latest episode of HealthBiz Briefs, guest Karen Schmidt, VP Oncology Market Lead at Q-Centrix, discusses why accurate and timely data is critical in cancer treatment and how improved data practices can lead to better outcomes and potentially life-saving care.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
Send us a textWith the election decided and over, Americans are looking at Republicans to make good on their campaign promises.One important promise to voters was to make America healthy again.But what does this agenda entail?And what impacts can we expect to see in healthcare?In this episode of CareTalk, David E. Williams and John Driscoll discuss the framework of Make America Healthy Again, covering what they have right, what they have wrong, and how it is set to change healthcare.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS(0:32) Sponsorship(1:59) Positives of Make America Healthy Again(3:31) Examining Chronic Disease Rates(4:54) Framework of Chronic Diseases(5:56) Health Policies on Pollution(7:02) The Gun Safety Epidemic(8:08) Government Regulations and Health Track Record(9:16) Contradictions in Make America Healthy Again(12:04) Hope for Change in American Healthcare
Send us a textThere's no shortage of data in healthcare.However, when it comes to deeper insights into patients' futures and provider costs, the industry is sorely lacking.Is it possible to unlock this data and create both better patient outcomes and more profits for providers?In this episode of HealthBiz Briefs, guest Brad Bostic, chairman and CEO of hc1, dives into the role of diagnostic testing labs and the ability to turn them into strategic assets by identifying risks before they become dangerous and costly problems.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
Send us a textReceiving a rare genetic disease diagnosis for yourself or a loved one is devastating news, especially when the diagnosed is a child.For families, navigating the challenges of these diagnoses requires more than just medical care, it takes a strong, compassionate support system.In this episode of CareTalk, David E. Williams and John Driscoll sit down with Effie Parks, advocate and host of the Once Upon a Gene podcast, to dive into the critical role of community during a rare disease diagnosis and the strong support system that has developed around parenting those afflicted.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS(0:36) Sponsorship(1:52) Welcome Effie Parks(2:31) Effie Parks' Journey into the Rare Disease Community(4:31) Why Effie Parks Started Once Upon a Gene(6:18) Advice to Families in the Rare Disease Community(7:12) Grappling with Grief and Guilt(10:45) Understanding Why We Experience Guilt(12:18) Examining Healthcare Policies That Impact Rare Diseases(14:43) How Healthcare Professionals Can Be More Sensitive to Families(16:27) Building a Supportive Rare Disease Community(18:19) Advice for Government Agencies When Approaching Rare Disease Policy(20:09) Engaging Patients and Families in Healthcare Policy(20:50) How the Entire Healthcare Ecosystem Can Become More Involved(22:46) Creating a Virtual Event for the Rare Disease Community(24:20) Areas of Hope in Rare Diseases
Send us a textNurses' primary job is to care for their patients, but often that valuable time is taken away with administrative tasks. Charting and other nonpatient activities stretch limited working hours and frequently pull nurses away from patients' bedside.The result, is worse care, declining patient safety, and error-ridden-charts.In this week's episode of HealthBiz Briefs, guest Hadassah Backman, CEO of Guardoc Health, shares how they're reducing nursing errors by streamlining tasks like charting and identifying mistakes before they become problems.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
I did this interview with John Driscoll, co-author of Pay the People! Why Fair Pay is Good for Business and Great for America, earlier this week, assuming that Harris would lose the election. And let's be clear: she did lose an election that should have been eminently winnable. Driscoll spelt it out clearly in a powerful The Hill article last week about how raising the minimum wage is the key to the White House for Harris. The problem with Harris, and most of the Democratic party, is their failure to offer a coherent and politically sellable economic alternative to Trumpism. John Driscoll and his group of successful business leaders at Patriotic Millionaires offer that alternative. It's not socialism, but it is an undisguised and unapologetic attempt to recognize the economic predicament of the American working class and to resurrect the American Dream by leveling the playing field. That's the way to defeat Trumpism. Not by smiling inanely and saying nothing.John Driscoll chairs the Waystar Corporation and is a senior advisor at Walgreens Boots Alliance. Previously, he was CEO at CareCentrix, president of Castlight, group president at Medco, and SVP at Oxford Health Plans. John also served as a captain in the U.S. Army Reserve and is a longtime board member of the Alliance for Hunger and The Patriotic Millionaires. The co-author, with Morris Pearl, of Pay the People! (The New Press), he lives in Stamford, Connecticut.Named as one of the "100 most connected men" by GQ magazine, Andrew Keen is amongst the world's best known broadcasters and commentators. In addition to presenting KEEN ON, he is the host of the long-running How To Fix Democracy show. He is also the author of four prescient books about digital technology: CULT OF THE AMATEUR, DIGITAL VERTIGO, THE INTERNET IS NOT THE ANSWER and HOW TO FIX THE FUTURE. Andrew lives in San Francisco, is married to Cassandra Knight, Google's VP of Litigation & Discovery, and has two grown children.Keen On is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit keenon.substack.com/subscribe
Send us a textMedical gaslighting is when a provider shirks a patient's concerns and leaves them without a diagnosis or treatment plan.Unfortunately, this experience is all too common for patients, especially women.So, how can patients tackle the problem and get the care they need?In this episode of CareTalk, David E. Williams and John Driscoll meet with guest Ilana Jacqueline, patient advocate and author of “Medical Gaslighting,” to discuss why medical gaslighting occurs and what patients can do to get the care they deserve.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS:(0:21) Sponsorship(1:40) Meet Ilana Jacqueline(2:21) Ilana Jacqueline's Experience with Medical Gaslighting(5:51) How Women Experience Medical Gaslighting(7:34) The Consequences of Medical Bias(9:54) Why We Need a Guide to Combat Medical Gaslighting(11:36) How Patients Should Handle Undiagnosed Conditions(13:26) Recognizing the Signs of Medical Gaslighting(15:18) The Moment Ilana Jacqueline Took Control of Her Health Journey(17:14) Bringing Awareness of Gaslighting to Providers(19:30) Approaching Pain Management as a Patient(22:50) Do Medical Providers Actually Review Feedback?
Send us a textTheoretically, having a full view of a patient's medical records could lead to more personalized treatment, stronger data security, and new research breakthroughs.But in practice? That's a tall order.Could AI be the solution?In this episode of HealthBiz Briefs, Bo Holland, Founder and CEO of All Clear ID, talks about the risks patients face with medical record security and the critical task of helping patients easily navigate and control their health data.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.
In today’s episode, Scott Becker covers key business stories including Costco’s revenue miss, lukewarm iPhone 16 sales, and companies’ frustrations with Gen Z workers. He also discusses China’s economic efforts, Dell’s office return mandate, and notable stock movements for Walgreens Boots Alliance and Trump Media.
Watch The X22 Report On Video No videos found Click On Picture To See Larger Picture The entire green new scam is going down the tubes, no matter how many subsidies, mandates the people are still rejecting it all and companies are folding. Stores are closing, the economy is in a downward spiral, people are catching on. The WaPo has begun the change of batter narrative. They are pushing the idea that [HRC] should replace [KH]. The problem is how are you going to replace a black women for a white women, they can't this is to wake the people up to the change. War is building and now Russia and NK have made a defense agreement. There is a new book out that talks about how Trump believes he still has foreign policy powers. Since the US was overthrown by domestic and foreign entities and they staged an insurrection against the President, the military has been activated and Trump is the Commander-in-Chief, welcome to COG. (function(w,d,s,i){w.ldAdInit=w.ldAdInit||[];w.ldAdInit.push({slot:13499335648425062,size:[0, 0],id:"ld-7164-1323"});if(!d.getElementById(i)){var j=d.createElement(s),p=d.getElementsByTagName(s)[0];j.async=true;j.src="//cdn2.customads.co/_js/ajs.js";j.id=i;p.parentNode.insertBefore(j,p);}})(window,document,"script","ld-ajs"); Economy Solar Co. Collapses, Customers Furious as Dems' Favorite Power Source Leaves Homeowners High and Dry Titan Solar told employees on June 13 that it was “closing its doors” because no one would buy the company, according to Time. Titan said that it put solar panels on more than 100,000 homes. The fate of consumers who have panels on their homes and no one to maintain them is uncertain. Over 2023 and 2024 to date, 16 major solar companies have filed for bankruptcy, Solar Insure reported. https://twitter.com/magszee39790/status/1803190222571618691?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1803190222571618691%7Ctwgr%5E21e1e5b21ce860c08dd8fad5cc6ca156bd063ea3%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.thegatewaypundit.com%2F2024%2F06%2Fsolar-co-collapses-customers-furious-dems-favorite-power%2F https://twitter.com/WEschenbach/status/1800919912715841750?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1800919912715841750%7Ctwgr%5E21e1e5b21ce860c08dd8fad5cc6ca156bd063ea3%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.thegatewaypundit.com%2F2024%2F06%2Fsolar-co-collapses-customers-furious-dems-favorite-power%2F Source: thegatewaypundit.com Bidenomics: More companies announce bankruptcies, shutter operations, citing inflation Retailers are closing nearly 3,200 stores this year, according to a recent analysis from CoreSight Research. The closures are a 24% increase from 2023. U.S. drug stores and pharmacy closures led to 8 million square feet of shuttered retail space this year, the research company said. It also notes that retailers are losing inventory and customers due to retail theft. “Retail shrink” is closely connected to “organized retail crime,” it notes. Out of the 3,200 being closed, the majority are being closed by roughly 30 retailers, with Family Dollar closing the most of over 600, according to the data, CBS News reported. Tupperware is the latest to announce it's permanently closing its last operating production plant in the U.S. in Hemingway, South Carolina. All of its 148 workers will be laid off, the first in September, followed by others in waves through next January. Tupperware announced its plans last week, stating it would continue to produce its products in a plant in Lerma, Mexico. Others closing stores this year include CVS Health, 7-Eleven, Rite Aid, Express, Walgreens Boots Alliance, Macy's, The Body Shop, Soft Surroundings, Burlington stores, Foot Locker, Carter's Big Lots, Dollar General, Abercrombie & Fitch Co., Big Lots, Best Buy and others, according to the CoreSight analysis. Source: justthenews.com